Neoadjuvant S-1 plus cisplatin-based chemoradiotherapy compared with surgery alone for locally advanced gastric cancer: Randomized, phase II trial

被引：0
|
作者：
Hong, Moonki
Yun, Kum-Hee
Jung, Minkyu
Rha, Sun Young
Kim, Hyoung-Il
Park, Jun Chul
Lee, Sang Kil
Choi, Seo Hee
Jung, Inkyung
Lim, Joon Seok
Hyung, Woo Jin
Koom, Woong Sub
Kim, Hyo Song
机构：
[1] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr,Coll Med, Seoul, South Korea
[2] Yonsei Univ, SongDang Inst Canc Res, Div Med Oncol, Dept Internal Med,Coll Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Div Gastroenterol, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Div Biostat, Seoul, South Korea
[7] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4076
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer
    Ahn, J.
    Choi, H.
    Cheon, S.
    Shin, S.
    Keum, K.
    Min, B.
    Baik, S.
    Kim, N.
    Jeung, H.
    Roh, J.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [33] A Pilot Study for Preoperative Concurrent Chemoradiotherapy with S-1 and Cisplatin for Locally Advanced Gastric Cancer
    Chung, Moon Jae
    Kim, Hyunki
    Jung, Yoon Suk
    Shin, Sung Kwan
    Hyung, Woo Jin
    Noh, Sung Hoon
    Seong, Jinsil
    Lee, Yong Chan
    Song, Si Young
    HEPATO-GASTROENTEROLOGY, 2013, 60 (122) : 382 - 386
  • [34] A PHASE II TRIAL OF NEOADJUVANT PREOPERATIVE CHEMORADIOTHERAPY WITH S-1 PLUS IRINOTECAN AND RADIATION IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER: CLINICAL FEASIBILITY AND RESPONSE RATE
    Sato, Takeo
    Ozawa, Heita
    Hatate, Kazuhiko
    Onosato, Wataru
    Naito, Masanori
    Nakamura, Takatoshi
    Ihara, Atsushi
    Koizumi, Wasaburo
    Hayakawa, Kazushige
    Okayasu, Isao
    Yamashita, Keishi
    Watanabe, Masahiko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (03): : 677 - 683
  • [35] Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with 2 and 4 courses of cisplatin/S-1 (CS) and docetaxel/cisplatin/S-1 (DCS) as neoadjuvant chemotherapy for locally advanced gastric cancer
    Nishikawa, K.
    Yoshikawa, T.
    Fujitani, K.
    Tanabe, K.
    Ito, S.
    Matsui, T.
    Miki, A.
    Nemoto, H.
    Sakamaki, K.
    Cho, H.
    Fukunaga, T.
    Kimura, Y.
    Hirabayashi, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Concurrent chemoradiotherapy with S-1 and cisplatin for locally advanced esophageal cancer
    Iwase, H.
    Shimada, M.
    Tsuzuki, T.
    Okeya, M.
    Kobayashi, K.
    Watanabe, H.
    Hibino, Y.
    Ryuge, N.
    Goto, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Yook, Jeong Hwan
    Park, Young-Kyu
    Kim, Young-Woo
    Kim, Jin Young
    Ryu, Min-Hee
    Rha, Sun Young
    Chung, Ik-Joo
    Kim, In-Ho
    Oh, Sang Cheul
    Yoo, Chang Hak
    Kang, Seok Yun
    Zang, Dae Young
    Kim, Sunju
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)
    Nishikawa, Kazuhiro
    Tsuburaya, Akira
    Yoshikawa, Takaki
    Kobayashi, Michiya
    Kawada, Junji
    Fukushima, Ryoji
    Matsui, Takanori
    Tanabe, Kazuaki
    Yamaguchi, Kazuya
    Yoshino, Shigefumi
    Takahashi, Masazumi
    Hirabayashi, Naoki
    Sato, Seiji
    Nemoto, Hiroshi
    Rino, Yasushi
    Nakajima, Junta
    Aoyama, Toru
    Miyagi, Yohei
    Oriuchi, Noboru
    Yamaguchi, Kensei
    Miyashita, Yumi
    Morita, Satoshi
    Sakamoto, Junichi
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 220 - 228
  • [39] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Sasaki, Kinro
    Onodera, Shinichi
    Otsuka, Kichiro
    Satomura, Hitoshi
    Kurayama, Eigo
    Kubo, Tsukasa
    Takahashi, Masakazu
    Ito, Jun
    Nakajima, Masanobu
    Yamaguchi, Satoru
    Miyachi, Kazuhito
    Kato, Hiroyuki
    MEDICAL ONCOLOGY, 2017, 34 (08)
  • [40] Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer
    Migita, Kazuhiro
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Matsuki, Atsushi
    Aizawa, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 102 - 109
12345